MedTrace Logo

Point of Care Test to Diagnosed Colorectal Cancer and Polyps in Low Middle Income Countries

NCT03173729 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 926

Last updated 2024-04-04

No results posted yet for this study

Summary

This is a-two phase study. Phase 1 will adapt a 3-metabolite biosensor that identifies patients with colorectal cancer (CRC) and precancerous polyps to Nigerian patients. Phase 2 will pilot test and evaluate the point-of-care (POC) biosensor device in Nigeria.

Conditions

Interventions

DIAGNOSTIC_TEST

Biosensor Point of Care Device

This device is a point of care urine-based metabolomic diagnostic test that detects metabolite biomarkers for CRC and polyps.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-11
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03173729 on ClinicalTrials.gov